Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Equine inhaler receives marketing authorisation
"Treating severe equine asthma can be challenging for veterinarians and horse owners" - Erich Schoett.

Aservo Equihaler® will be available for EU distribution in 2020

A novel equine inhaler set to benefit horses suffering from severe equine asthma has been granted marketing approval by the European Commission.


Marking an industry-first in equine medicine, the Aservo Equihaler® is the culmination of more than a decade of collaboration between Boehringer Ingelheim’s human pharma and animal health R&D groups. It is expected to be available for veterinary surgeons in the EU in 2020.


The inhaler incorporates a unique Soft Mist Technology®, found in the human Respimat® inhaler. This allows the active ingredient - ciclesonide - to be inhaled deep into the lung, thereby reducing the risk of lower airway inflammation.

Designed specifically for horses, the inhaler also features an ergonomic handle, dosing lever for ease of handling and a nostril adaptor that fits inside the nostril of the horse to allow for easy inhalation.

Erich Schoett, global business head of equine for the Boehringer Ingelheim Animal Health Business Unit, said: “Treating severe equine asthma can be challenging for veterinarians and horse owners, who struggle to find safe and effective ways to help horses breathe.


“Bringing a new, safe and effective treatment to the market is something that we can really be proud of. It is a strong indicator of the commitment that Boehringer Ingelheim has to the health and welfare of horses, and to the investment that we make into continuing to advance therapies through collaboration and innovation.”

Become a member or log in to add this story to your CPD history

Free bloat webinar planned for dog owners

News Story 1
 The Kennel Club is inviting dog owners to attend a free webinar on gastric dilation-volvulus syndrome, also known as bloat.

Part of its health webinar series, the session will take place from 7pm to 8pm on 12 November. It will explore what scientific research has revealed about causes, symptoms, breed susceptibilities, diagnostic approaches, and treatment options, as well as looking at what future research could uncover.

The talk will be hosted by Mark Dunning, professor of small animal internal medicine at the University of Nottingham, and will include a 30-minute Q&A session.

Places can be booked here

Click here for more...
News Shorts
FIVP to represent independent practices at London Vet Show

The Federation of Independent Veterinary Practices (FIVP) will be at stand (S05) at this year's London Vet Show.

The not-for-profit organisation will be explaining how its expertise and resources can help independent practices to thrive in a competitive industry. It will also share how it has been representing independent practices in the ongoing CMA investigation.

On Thursday, FIVP member Steve Carter will be available to discuss how veterinary surgeons and nurses can pursue practice ownership.

FIVP will also be offering independent practices three months of free membership if they sign up at the stand.

Rita Dingwall, FIVP business development manager, said: "It's a wonderful opportunity to discuss our representation in the CMA enquiry and connect with like-minded individuals who share our passion for independent practice."